C
KRYS icon

Certuity’s Krystal Biotech KRYS Stock Holding History

Certuity’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Hold
800
– – 0.01% 502
2026
Q1 		$207K Buy
+800
New +$213K 0.01% 591
2025
Q2 		– Sell
-2,585
Closed -$466K – 444
2025
Q1 		$466K Buy
2,585
+1,220
+89% +$205K 0.05% 195
2024
Q4 		$214K Buy
+1,365
New +$242K 0.02% 337

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Certuity's KRYS Position: Q2 2026 in Review

Certuity held its Krystal Biotech (KRYS) position steady in Q2 2026 at 800 shares worth $297K. The position accounts for 0.01% of the portfolio, ranked #502.

Certuity first reported a position in KRYS in Q4 2024 and has held it in 4 quarters since. The position peaked at $466K in Q1 2025. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Certuity held 800 shares of Krystal Biotech worth $297K as of Q2 2026.
  • Certuity left its Krystal Biotech share count unchanged in Q2 2026.
  • Krystal Biotech made up 0.01% of Certuity's portfolio in Q2 2026, its #502 holding.
  • Certuity first reported a position in Krystal Biotech in Q4 2024 and has held it in 4 quarters since.
  • Certuity's Krystal Biotech position peaked at $466K in Q1 2025.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.